Unknown

Dataset Information

0

LukS-PV Induces Apoptosis via the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells.


ABSTRACT: Evidence suggests that histone modification disorders are involved in leukemia pathogenesis. We previously reported that LukS-PV, a component of Panton-Valentine leukocidin (PVL), has antileukemia activities that can induce differentiation, increase apoptosis, and inhibit proliferation of acute myeloid leukemia (AML) cells. Furthermore, LukS-PV inhibited hepatoma progression by regulating histone deacetylation, speculating that LukS-PV may exert antileukemia activity by targeting histone modification regulators. In this study, the results showed that LukS-PV induced apoptosis by downregulating the methyltransferase SET8 and its target histone H4 monomethylated at Lys 20 (H4K20me1). Furthermore, chromatin immunoprecipitation sequencing and polymerase chain reaction identified the kinase PIK3CB as a downstream target gene for apoptosis mediated by SET8/H4K20me1. Finally, our results indicated that LukS-PV induced apoptosis via the PIK3CB-AKT-FOXO1 signaling pathway by targeting SET8. This study indicates that SET8 downregulation is one of the mechanisms by which LukS-PV induces apoptosis in AML cells, suggesting that SET8 may be a potential therapeutic target for AML. Furthermore, LukS-PV may be a drug candidate for the treatment of AML that targets epigenetic modifications.

SUBMITTER: Xu LF 

PROVIDER: S-EPMC8565356 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

LukS-PV Induces Apoptosis <i>via</i> the SET8-H4K20me1-PIK3CB Axis in Human Acute Myeloid Leukemia Cells.

Xu Liang Fei LF   Shi Lan L   Zhang Shan Shan SS   Ding Peng Sheng PS   Ma Fan F   Song Kai Di KD   Qiang Ping P   Chang Wen Jiao WJ   Dai Yuan Yuan YY   Mei Yi De Y   Ma Xiao Ling XL  

Frontiers in oncology 20211020


Evidence suggests that histone modification disorders are involved in leukemia pathogenesis. We previously reported that LukS-PV, a component of Panton-Valentine leukocidin (PVL), has antileukemia activities that can induce differentiation, increase apoptosis, and inhibit proliferation of acute myeloid leukemia (AML) cells. Furthermore, LukS-PV inhibited hepatoma progression by regulating histone deacetylation, speculating that LukS-PV may exert antileukemia activity by targeting histone modific  ...[more]

Similar Datasets

| S-EPMC5323132 | biostudies-literature
| S-EPMC7115168 | biostudies-literature
| S-EPMC4414159 | biostudies-literature
| S-EPMC8438695 | biostudies-literature
| S-EPMC9175482 | biostudies-literature
| S-EPMC8688515 | biostudies-literature
| S-EPMC11910327 | biostudies-literature
| S-EPMC4119075 | biostudies-literature
| S-EPMC7448420 | biostudies-literature
| S-EPMC10564230 | biostudies-literature